Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients
Conditions: Quality of Life; Type 2 Diabetes; Metformin+Sitagliptin Intervention: Drug: Metformin / Sitagliptin Oral Tablet Sponsor: Getz Pharma Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Janumet | Januvia | Metformin | Pharmaceuticals | Research